Institutional
First Light Asset Management, LLC
CIK 0001600004
$1.12B
Reported AUM
35
Positions
Q1 2026
Period
2026-05-15
Filed
The Brief · First Light Asset Management, LLC · Q1 2026
AI · grounded in 13F
First Light Asset Management, LLC closed its position in IRON for a reduction of $41.5M. The fund also exited its holding in MDGL for $38.9M and trimmed its stake in VERA by 63.9%. On the buy side, the fund established new positions in TLSI for $20.3M and TECX for $20M. Additionally, it increased its share count in APGE by 102.4%.
Portfolio · Q1 2026
Top holdings
| # | Stock | Issuer | Price | Day % | 1Y Gr. | 5Y Gr. | Value | % of book | Δ shares (QoQ) | Status |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | AXGN | AXOGEN INC | $41.35 | -0.05% | 226.36% | 142.38% | $132.6M | 11.88% | — | HELD |
| 2 | PVLA | PALVELLA THERAPEUTICS INC | $150.19 | 5.32% | 301.89% | -65.93% | $122.3M | 10.96% | — | HELD |
| 3 | NEO | NEOGENOMICS INC | $15.88 | 3.99% | 207.75% | -67.34% | $72.2M | 6.47% | — | HELD |
| 4 | SIBN | SI-BONE INC | $17.99 | -2.44% | 3.45% | -26.30% | $67.6M | 6.06% | — | HELD |
| 5 | CNTA | CENTESSA PHARMACEUTICALS LIMITED | — | — | 0.00% | — | $62.0M | 5.56% | — | HELD |
| 6 | APGE | APOGEE THERAPEUTICS INC | $134.30 | 0.07% | 255.36% | 484.79% | $48.5M | 4.35% | — | HELD |
| 7 | AMLX | AMYLYX PHARMACEUTICALS INC | $20.75 | 5.17% | 151.20% | -41.09% | $44.3M | 3.97% | — | HELD |
| 8 | TWST | TWIST BIOSCIENCE CORPORATION | $91.33 | 6.86% | 166.64% | -20.67% | $41.8M | 3.74% | — | HELD |
| 9 | CRNX | CRINETICS PHARMACEUTICALS INC | $83.63 | -0.30% | 201.02% | 255.56% | $39.6M | 3.55% | — | HELD |
| 10 | MASS | 908 DEVICES INC | $7.64 | 0.53% | 19.00% | -78.78% | $37.2M | 3.33% | — | HELD |
| 11 | NPCE | NEUROPACE INC | $13.75 | 0.81% | 52.95% | -35.26% | $32.3M | 2.90% | — | HELD |
| 12 | EWTX | EDGEWISE THERAPEUTICS INC | $41.12 | 3.45% | 177.78% | 150.95% | $31.6M | 2.83% | — | HELD |
| 13 | ANAB | ANAPTYS BIO INC | $55.04 | 5.56% | 224.54% | 212.89% | $31.4M | 2.81% | — | HELD |
| 14 | SLP | SIMULATIONS PLUS INC | $18.30 | -0.16% | 42.97% | -57.98% | $31.1M | 2.79% | — | HELD |
| 15 | GH | GUARDANT HEALTH | $152.35 | 5.75% | 264.70% | 18.69% | $25.9M | 2.32% | — | HELD |
| 16 | TNDM | TANDEM DIABETES CARE INC | $19.01 | 2.26% | 18.31% | -83.76% | $25.2M | 2.26% | — | HELD |
| 17 | ATRC | ATRICURE INC | $40.15 | -1.81% | 16.68% | -45.46% | $20.8M | 1.87% | — | HELD |
| 18 | TLSI | TRISALUS LIFE SCIENCES INC | $4.56 | 4.11% | 9.09% | -53.61% | $20.3M | 1.82% | — | HELD |
| 19 | TECX | TECTONIC THERAPEUTICS INC | $28.51 | 0.28% | 37.53% | -64.33% | $20.0M | 1.79% | — | HELD |
| 20 | IRTC | IRHYTHM TECHNOLOGIES | $119.08 | -2.74% | -27.82% | 149.12% | $19.8M | 1.78% | — | HELD |
| 21 | SEPN | SEPTERNA INC | $35.18 | 4.67% | 187.06% | 38.59% | $17.6M | 1.58% | — | HELD |
| 22 | ESTA | ESTABLISHMENT LABS HOLDINGS | $93.48 | 1.69% | 126.22% | 24.69% | $17.5M | 1.57% | — | HELD |
| 23 | HCAT | HEALTH CATALYST INC | $2.08 | -3.70% | -41.05% | -96.20% | $16.4M | 1.47% | — | HELD |
| 24 | OMCL | OMNICELL INC | $37.11 | -10.36% | 24.70% | -76.10% | $16.4M | 1.47% | — | HELD |
| 25 | KRMD | KORU MEDICAL SYSTEMS INC | $4.11 | 0.98% | 18.10% | 26.46% | $16.3M | 1.46% | — | HELD |
| 26 | WGS | GENEDX HOLDINGS CORP | $68.96 | 8.28% | -33.27% | -78.37% | $15.6M | 1.40% | — | HELD |
| 27 | WVE | WAVE LIFE SCIENCES LTD | $5.76 | -0.86% | -34.88% | -11.22% | $13.4M | 1.20% | — | HELD |
| 28 | VERA | VERA THERAPEUTICS INC | $33.05 | 1.66% | 55.85% | 121.51% | $12.6M | 1.13% | — | HELD |
| 29 | MDXG | MIMEDX GROUP INC | $4.27 | 0.95% | -40.36% | -71.07% | $11.2M | 1.01% | — | HELD |
| 30 | BFLY | BUTTERFLY NETWORK INC | $8.17 | 15.07% | 480.00% | -34.30% | $10.7M | 0.96% | — | HELD |
| 31 | SGP | SPYGLASS PHARMA INC | $22.72 | 3.70% | — | — | $9.7M | 0.87% | — | HELD |
| 32 | ORGO | ORGANOGENESIS HOLDINGS INC | $2.45 | -2.78% | — | — | $8.3M | 0.74% | — | HELD |
| 33 | PCVX | VAXCYTE INC | $55.96 | 5.62% | — | — | $8.2M | 0.74% | — | HELD |
| 34 | ELVN | ENLIVEN THERAPEUTICS INC | $53.95 | 1.85% | — | — | $7.9M | 0.71% | — | HELD |
| 35 | RYTM | RHYTHM PHARMACEUTICALS INC | $105.74 | -0.74% | — | — | $7.6M | 0.68% | — | HELD |
Source: SEC EDGAR · accession 0001999371-26-010896. 13F discloses long positions only — shorts, foreign equities, and options are excluded.